Buprenorphine

Trade Name: 
Belbuca
Manufacturer/Distributor: 
Purdue Pharma
Classification: 
Opioid analgesic
ATC Class: 
N02AE01 - buprenorphine
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2017/06/21
Date Marketed in Canada (yyyy/mm/dd): 
2018/01/17
Presentation: 
Buccal film: 75 mcg. DIN: 02465221
Buccal film: 150 mcg. DIN: 02465248
Buccal film: 300 mcg. DIN: 02465256
Buccal film: 450 mg. DIN: 02465264
Comments: 
Buprenorphine buccal soluble film is indicated for the management of pain severe enough to require daily, continuous, long-term treatment and that is opioid-responsive; and for which alternative options are inadequate. It is not indicated as an as-needed analgesic.